Related references
Note: Only part of the references are listed.PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma
Francesco Sabbatino et al.
CLINICAL CANCER RESEARCH (2016)
Safety and feasibility of endoscopic biliary radiofrequency ablation treatment of extrahepatic cholangiocarcinoma
A. Laquiere et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2016)
Laminin-332 sustains chemoresistance and quiescence as part of the human hepatic cancer stem cell niche
Olivier Govaere et al.
JOURNAL OF HEPATOLOGY (2016)
The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology
Cristina R. Ferrone et al.
ANNALS OF SURGICAL ONCOLOGY (2016)
ACG Clinical Guideline: Primary Sclerosing Cholangitis
Keith D. Lindor et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2015)
Profiles of Cancer Stem Cell Subpopulations in Cholangiocarcinomas
Vincenzo Cardinale et al.
AMERICAN JOURNAL OF PATHOLOGY (2015)
Difficult Diagnostic Problems in Pancreatobiliary Neoplasia
Jacob R. Bledsoe et al.
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2015)
Clinical presentation, risk factors and staging systems of cholangiocarcinoma
Ruben R. Plentz et al.
BEST PRACTICE & RESEARCH CLINICAL GASTROENTEROLOGY (2015)
Omega-3 Polyunsaturated Fatty Acids Upregulate 15-PGDH Expression in Cholangiocarcinoma Cells by Inhibiting miR-26a/b Expression
Lu Yao et al.
CANCER RESEARCH (2015)
miR-21 Inhibition Reduces Liver Fibrosis and Prevents Tumor Development by Inducing Apoptosis of CD24+ Progenitor Cells
Jing Zhang et al.
CANCER RESEARCH (2015)
Cell-of-Origin of Cancer versus Cancer Stem Cells: Assays and Interpretations
Kiera Rycaj et al.
CANCER RESEARCH (2015)
Volatile organic compounds in bile for early diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis: a pilot study
Udayakumar Navaneethan et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Comparative effectiveness of biliary brush cytology and intraductal biopsy for detection of malignant biliary strictures: a systematic review and meta-analysis
Udayakumar Navaneethan et al.
GASTROINTESTINAL ENDOSCOPY (2015)
Metastasis-associated in colon cancer 1 is an independent prognostic biomarker for survival in klatskin tumor patients
Andri Lederer et al.
HEPATOLOGY (2015)
Four DNA Methylation Biomarkers in Biliary Brush Samples Accurately Identify the Presence of Cholangiocarcinoma
Kim Andresen et al.
HEPATOLOGY (2015)
Global DNA methylation and hydroxymethylation differ in hepatocellular carcinoma and cholangiocarcinoma and relate to survival rate
Silvia Udali et al.
HEPATOLOGY (2015)
IL-33 Facilitates Oncogene-Induced Cholangiocarcinoma in Mice by an Interleukin-6-Sensitive Mechanism
Daisaku Yamada et al.
HEPATOLOGY (2015)
Differential Effects of Targeting Notch Receptors in a Mouse Model of Liver Cancer
Erik G. Huntzicker et al.
HEPATOLOGY (2015)
Epigenetic regulation in the carcinogenesis of cholangiocarcinoma
Nai-Jung Chiang et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2015)
WNT signaling drives cholangiocarcinoma growth and can be pharmacologically inhibited
Luke Boulter et al.
JOURNAL OF CLINICAL INVESTIGATION (2015)
Enhanced antitumour drug delivery to cholangiocarcinoma through the apical sodium-dependent bile acid transporter (ASBT)
Elisa Lozano et al.
JOURNAL OF CONTROLLED RELEASE (2015)
Impact of microenvironment and stem-like plasticity in cholangiocarcinoma: Molecular networks and biological concepts
Chiara Raggi et al.
JOURNAL OF HEPATOLOGY (2015)
Activation of biliary tree stem cells within peribiliary glands in primary sclerosing cholangitis
Guido Carpino et al.
JOURNAL OF HEPATOLOGY (2015)
Radiofrequency Ablation in the Treatment of Unresectable Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-Analysis
Kichang Han et al.
JOURNAL OF VASCULAR AND INTERVENTIONAL RADIOLOGY (2015)
Genomic spectra of biliary tract cancer
Hiromi Nakamura et al.
NATURE GENETICS (2015)
A new mouse model that closely resembles human cholangiocarcinoma
Isobel Leake
Nature Reviews Gastroenterology & Hepatology (2015)
Intrahepatic Cholangiocarcinoma: expert consensus statement
Sharon M. Weber et al.
HPB (2015)
Hilar Cholangiocarcinoma: expert consensus statement
John C. Mansour et al.
HPB (2015)
Whole-genome mutational landscape of liver cancers displaying biliary phenotype reveals hepatitis impact and molecular diversity
Akihiro Fujimoto et al.
NATURE COMMUNICATIONS (2015)
Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Daniela Sia et al.
NATURE COMMUNICATIONS (2015)
Efficacy and safety of photodynamic therapy for unresectable cholangiocarcinoma: A meta-analysis
Yi Lu et al.
CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY (2015)
Metformin inhibits tumor growth by regulating multiple miRNAs in human cholangiocarcinoma
Xingming Jiang et al.
ONCOTARGET (2015)
The Global Burden of Cancer 2013 Global Burden of Disease Cancer Collaboration
Christina Fitzmaurice et al.
JAMA ONCOLOGY (2015)
Pathogenesis and classification of intrahepatic cholangiocarcinoma: different characters of perihilar large duct type versus peripheral small duct type
Shinichi Aishima et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2015)
Comparative Effectiveness of Hepatic Artery Based Therapies for Unresectable Intrahepatic Cholangiocarcinoma
Lucas M. Boehm et al.
JOURNAL OF SURGICAL ONCOLOGY (2015)
Bile proteomics for differentiation of malignant from benign biliary strictures: a pilot study
Udayakumar Navaneethan et al.
GASTROENTEROLOGY REPORT (2015)
Tumour cell-derived extracellular vesicles interact with mesenchymal stem cells to modulate the microenvironment and enhance cholangiocarcinoma growth
Hiroaki Haga et al.
JOURNAL OF EXTRACELLULAR VESICLES (2015)
Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials
J. W. Valle et al.
ANNALS OF ONCOLOGY (2014)
Second-line chemotherapy in advanced biliary cancer: a systematic review
A. Lamarca et al.
ANNALS OF ONCOLOGY (2014)
Hedgehog Signaling Between Cancer Cells and Hepatic Stellate Cells in Promoting Cholangiocarcinoma
Younjoo Kim et al.
ANNALS OF SURGICAL ONCOLOGY (2014)
Concurrent analysis of human equilibrative nucleoside transporter 1 and ribonucleotide reductase subunit 1 expression increases predictive value for prognosis in cholangiocarcinoma patients treated with adjuvant gemcitabine-based chemotherapy
H. Sasaki et al.
BRITISH JOURNAL OF CANCER (2014)
Proposal to modify the International Union Against Cancer staging system for perihilar cholangiocarcinomas
T. Ebata et al.
BRITISH JOURNAL OF SURGERY (2014)
Cancer stem cells: A contentious hypothesis now moving forward
Michael L. O'Connor et al.
CANCER LETTERS (2014)
Evolution of the Cancer Stem Cell Model
Antonija Kreso et al.
CELL STEM CELL (2014)
Molecular Pathogenesis of Cholangiocarcinoma
Sumera Rizvi et al.
DIGESTIVE DISEASES (2014)
Activating Mutations in PTPN3 Promote Cholangiocarcinoma Cell Proliferation and Migration and Are Associated With Tumor Recurrence in Patients
Qiang Gao et al.
GASTROENTEROLOGY (2014)
Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
Olivier Govaere et al.
GUT (2014)
Global Alterations of DNA Methylation in Cholangiocarcinoma Target the Wnt Signaling Pathway
Benjamin Goeppert et al.
HEPATOLOGY (2014)
Fibroblast Growth Factor Receptor 2 Tyrosine Kinase Fusions Define a Unique Molecular Subtype of Cholangiocarcinoma
Yasuhito Arai et al.
HEPATOLOGY (2014)
Liver-Specific Knockout of GRP94 in Mice Disrupts Cell Adhesion, Activates Liver Progenitor Cells, and Accelerates Liver Tumorigenesis
Wan-Ting Chen et al.
HEPATOLOGY (2014)
Extracellular Vesicle Noncoding RNA: New Players in the Diagnosis and Pathogenesis of Cholangiocarcinoma
Tushar Patel
HEPATOLOGY (2014)
Conjugated Bile Acids Promote Cholangiocarcinoma Cell Invasive Growth Through Activation of Sphingosine 1-Phosphate Receptor 2
Runping Liu et al.
HEPATOLOGY (2014)
Cholangiocarcinoma Development: The Resurgence of Bile Acids
Luca Maroni et al.
HEPATOLOGY (2014)
Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Antonio Sica et al.
HEPATOLOGY (2014)
Desmoplastic Stroma and Cholangiocarcinoma: Clinical Implications and Therapeutic Targeting
Alphonse E. Sirica et al.
HEPATOLOGY (2014)
Human Bile Contains MicroRNA-Laden Extracellular Vesicles That Can Be Used for Cholangiocarcinoma Diagnosis
Ling Li et al.
HEPATOLOGY (2014)
Pathological diagnosis of flat epithelial lesions of the biliary tract with emphasis on biliary intraepithelial neoplasia
Yasunori Sato et al.
JOURNAL OF GASTROENTEROLOGY (2014)
Non-canonical Hedgehog signaling contributes to chemotaxis in cholangiocarcinoma
Nataliya Razumilava et al.
JOURNAL OF HEPATOLOGY (2014)
EGF/EGFR axis contributes to the progression of cholangiocarcinoma through the induction of an epithelial-mesenchymal transition
Audrey Claperon et al.
JOURNAL OF HEPATOLOGY (2014)
Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater et al.
JOURNAL OF HEPATOLOGY (2014)
Epithelial cell adhesion molecule is a prognosis marker for intrahepatic cholangiocarcinoma
Laurent Sulpice et al.
JOURNAL OF SURGICAL RESEARCH (2014)
Morphological subclassification of intrahepatic cholangiocarcinoma: etiological, clinicopathological, and molecular features
Jau-Yu Liau et al.
MODERN PATHOLOGY (2014)
Cocarcinogenic Effects of Intrahepatic Bile Acid Accumulation in Cholangiocarcinoma Development
Elisa Lozano et al.
MOLECULAR CANCER RESEARCH (2014)
Mutant IDH inhibits HNF-4α to block hepatocyte differentiation and promote biliary cancer
Supriya K. Saha et al.
NATURE (2014)
The emerging roles of microvesicles in liver diseases
Sara Lemoinne et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2014)
New Routes to Targeted Therapy of Intrahepatic Cholangiocarcinomas Revealed by Next-Generation Sequencing
Jeffrey S. Ross et al.
ONCOLOGIST (2014)
Clinicopathologic Significance of Sox2, CD44 and CD44v6 Expression in Intrahepatic Cholangiocarcinoma
Mi Jin Gu et al.
PATHOLOGY & ONCOLOGY RESEARCH (2014)
XIAP Antagonist Embelin Inhibited Proliferation of Cholangiocarcinoma Cells
Cody J. Wehrkamp et al.
PLOS ONE (2014)
Cholangiocarcinoma: Molecular Pathways and Therapeutic Opportunities
Sumera Rizvi et al.
SEMINARS IN LIVER DISEASE (2014)
Endoscopic radiofrequency ablation for malignant biliary obstruction: a nationwide retrospective study of 84 consecutive applications
Werner Dolak et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2014)
Hilar Cholangiocarcinoma
Victor M. Zaydfudim et al.
SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA (2014)
Activated macrophages promote Wnt/β-catenin signaling in cholangiocarcinoma cells
Watcharin Loilome et al.
TUMOR BIOLOGY (2014)
Cystic and micropapillary epithelial changes of peribiliary glands might represent a precursor lesion of biliary epithelial neoplasms
Yasunori Sato et al.
VIRCHOWS ARCHIV (2014)
Hepatitis B virus infection and intrahepatic cholangiocarcinoma
Hua-Bang Zhou et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2014)
Mutational landscape of intrahepatic cholangiocarcinoma
Shanshan Zou et al.
NATURE COMMUNICATIONS (2014)
Multigene mutational profiling of cholangiocarcinomas identifies actionable molecular subgroups
Michele Simbolo et al.
ONCOTARGET (2014)
Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma
Mitesh J. Borad et al.
PLOS GENETICS (2014)
Evolution of Surgical Treatment for Perihilar Cholangiocarcinoma A Single-Center 34-Year Review of 574 Consecutive Resections
Masato Nagino et al.
ANNALS OF SURGERY (2013)
Comparison of the Sixth and the Seventh Editions of the UICC Classification for Perihilar Cholangiocarcinoma
Benjamin Juntermanns et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Intra-arterial Therapy for Advanced Intrahepatic Cholangiocarcinoma: A Multi-institutional Analysis
Omar Hyder et al.
ANNALS OF SURGICAL ONCOLOGY (2013)
Simvastatin enhances the chemotherapeutic efficacy of S-1 against bile duct cancer: E2F-1/TS downregulation might be the mechanism
Jian-Peng Cai et al.
ANTI-CANCER DRUGS (2013)
Surgical outcomes of 230 resected hilar cholangiocarcinoma in a single centre
Sun Choon Song et al.
ANZ JOURNAL OF SURGERY (2013)
The roles of Notch1 expression in the migration of intrahepatic cholangiocarcinoma
Qi Zhou et al.
BMC CANCER (2013)
Therapeutic Effects of Deleting Cancer-Associated Fibroblasts in Cholangiocarcinoma
Joachim C. Mertens et al.
CANCER RESEARCH (2013)
HDAC6 Inhibition Restores Ciliary Expression and Decreases Tumor Growth
Sergio A. Gradilone et al.
CANCER RESEARCH (2013)
Recent advances in the morphological and functional heterogeneity of the biliary epithelium
Yuyan Han et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2013)
Pathogenesis, Diagnosis, and Management of Cholangiocarcinoma
Sumera Rizvi et al.
GASTROENTEROLOGY (2013)
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Daniela Sia et al.
GASTROENTEROLOGY (2013)
Inhibition of hedgehog signaling attenuates carcinogenesis in vitro and increases necrosis of cholangiocellular carcinoma
Mona El Khatib et al.
HEPATOLOGY (2013)
Platelet-Derived Growth Factor-D and Rho GTPases Regulate Recruitment of Cancer-Associated Fibroblasts in Cholangiocarcinoma
Massimiliano Cadamuro et al.
HEPATOLOGY (2013)
Polo-Like Kinase 2 Is a Mediator of Hedgehog Survival Signaling in Cholangiocarcinoma
Christian D. Fingas et al.
HEPATOLOGY (2013)
Expression of SLC22A1 Variants May Affect the Response of Hepatocellular Carcinoma and Cholangiocarcinoma to Sorafenib
Elisa Herraez et al.
HEPATOLOGY (2013)
Constitutive Notch2 signaling induces hepatic tumors in mice
Michael T. Dill et al.
HEPATOLOGY (2013)
Molecular Profiling of Stroma Identifies Osteopontin as an Independent Predictor of Poor Prognosis in Intrahepatic Cholangiocarcinoma
Laurent Sulpice et al.
HEPATOLOGY (2013)
Hepatic Myofibroblasts Promote the Progression of Human Cholangiocarcinoma Through Activation of Epidermal Growth Factor Receptor
Audrey Claperon et al.
HEPATOLOGY (2013)
Hilar cholangiocarcinoma and pancreatic ductal adenocarcinoma share similar histopathologies, immunophenotypes, and development-related molecuies
Chihiro Gandou et al.
HUMAN PATHOLOGY (2013)
Structural and Biophysical Characterization of the Interactions between the Death Domain of Fas Receptor and Calmodulin
Timothy F. Fernandez et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Cancer stem cells in the development of liver cancer
Taro Yamashita et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Prognostic Significance of Tumor Doubling Time in Mass-Forming Type Cholangiocarcinoma
Agostino Maria De Rose et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2013)
Contrast enhanced CT-scan to diagnose intrahepatic cholangiocarcinoma in patients with cirrhosis
Massimo Iavarone et al.
JOURNAL OF HEPATOLOGY (2013)
FUT2 and FUT3 genotype determines CA19-9 cut-off values for detection of cholangiocarcinoma in patients with primary sclerosing cholangitis
Andreas Wannhoff et al.
JOURNAL OF HEPATOLOGY (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Exome sequencing identifies distinct mutational patterns in liver fluke-related and non-infection-related bile duct cancers
Waraporn Chan-on et al.
NATURE GENETICS (2013)
Exome sequencing identifies frequent inactivating mutations in BAP1, ARID1A and PBRM1 in intrahepatic cholangiocarcinomas
Yuchen Jiao et al.
NATURE GENETICS (2013)
Mutations in isocitrate dehydrogenase 1 and 2 occur frequently in intrahepatic cholangiocarcinomas and share hypermethylation targets with glioblastomas
P. Wang et al.
ONCOGENE (2013)
Biliary Stent Therapy for Dominant Strictures in Patients Affected by Primary Sclerosing Cholangitis
Bassam Abu-Wasel et al.
PATHOBIOLOGY (2013)
Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
Chun-Nan Yeh et al.
PLOS ONE (2013)
The Expression of CD90/Thy-1 in Hepatocellular Carcinoma: An In Vivo and In Vitro Study
Caecilia Hapsari Ceriapuri Sukowati et al.
PLOS ONE (2013)
Mouse model of intrahepatic cholangiocarcinoma validates FIG-ROS as a potent fusion oncogene and therapeutic target
Anna Saborowski et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Identification of Targetable FGFR Gene Fusions in Diverse Cancers
Yi-Mi Wu et al.
CANCER DISCOVERY (2013)
Improvement in Perioperative and Long-term Outcome After Surgical Treatment of Hilar Cholangiocarcinoma Results of an Italian Multicenter Analysis of 440 Patients
Gennaro Nuzzo et al.
ARCHIVES OF SURGERY (2012)
Endoscopic stenting for hilar cholangiocarcinoma: efficacy of unilateral and bilateral placement of plastic and metal stents in a retrospective review of 480 patients
Manuel Jose Antunes Liberato et al.
BMC GASTROENTEROLOGY (2012)
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
Douglas Hanahan et al.
CANCER CELL (2012)
Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
Jeffrey A. Magee et al.
CANCER CELL (2012)
An oestrogen receptor β-selective agonist exerts anti-neoplastic effects in experimental intrahepatic cholangiocarcinoma
Marco Marzioni et al.
DIGESTIVE AND LIVER DISEASE (2012)
Human equilibrative nucleoside transporter 1 (hENT1) expression is a potential predictive tool for response to gemcitabine in patients with advanced cholangiocarcinoma
I. Borbath et al.
EUROPEAN JOURNAL OF CANCER (2012)
Genomic and Genetic Characterization of Cholangiocarcinoma Identifies Therapeutic Targets for Tyrosine Kinase Inhibitors
Jesper B. Andersen et al.
GASTROENTEROLOGY (2012)
Efficacy of Neoadjuvant Chemoradiation, Followed by Liver Transplantation, for Perihilar Cholangiocarcinoma at 12 US Centers
Sarwa Darwish Murad et al.
GASTROENTEROLOGY (2012)
Progranulin and cholangiocarcinoma: another bad boy on the block!
Domenico Alvaro
GUT (2012)
Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinoma
Heather Francis et al.
GUT (2012)
Guidelines for the diagnosis and treatment of cholangiocarcinoma: an update
Shahid A. Khan et al.
GUT (2012)
Cystic and papillary neoplasm involving peribiliary glands: A biliary counterpart of branch-type intraductal papillary mucinous cystic neoplasm?
Yasuni Nakanuma et al.
HEPATOLOGY (2012)
Predictors of pretransplant dropout and posttransplant recurrence in patients with perihilar cholangiocarcinoma
Sarwa Darwish Murad et al.
HEPATOLOGY (2012)
Cholangiocarcinoma: A cancer in search of the right classification
Vincenzo Cardinale et al.
HEPATOLOGY (2012)
Mucin-producing cholangiocarcinoma might derive from biliary tree stem/progenitor cells located in peribiliary glands
Vincenzo Cardinale et al.
HEPATOLOGY (2012)
Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
Mina Komuta et al.
HEPATOLOGY (2012)
Overexpression of epithelial-mesenchymal transition-related markers according to cell dedifferentiation: clinical implications as an independent predictor of poor prognosis in cholangiocarcinoma
Han Suk Ryu et al.
HUMAN PATHOLOGY (2012)
Identification of CXCL5/ENA-78 as a factor involved in the interaction between cholangiocarcinoma cells and cancer-associated fibroblasts
Hirohisa Okabe et al.
INTERNATIONAL JOURNAL OF CANCER (2012)
Biliary tree stem/progenitor cells in glands of extrahepatic and intraheptic bile ducts: an anatomical in situ study yielding evidence of maturational lineages
Guido Carpino et al.
JOURNAL OF ANATOMY (2012)
Cholangiocarcinomas can originate from hepatocytes in mice
Biao Fan et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Intrahepatic cholangiocarcinoma can arise from Notch-mediated conversion of hepatocytes
Sayaka Sekiya et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Role of the stromal-derived factor-1 (SDF-1)-CXCR4 axis in the interaction between hepatic stellate cells and cholangiocarcinoma
Alessandra Gentilini et al.
JOURNAL OF HEPATOLOGY (2012)
Are common factors involved in the pathogenesis of primary liver cancers? A meta-analysis of risk factors for intrahepatic cholangiocarcinoma
William C. Palmer et al.
JOURNAL OF HEPATOLOGY (2012)
No Correlation between the Expression of FXR and Genes Involved in Multidrug Resistance Phenotype of Primary Liver Tumors
P. Martinez-Becerra et al.
MOLECULAR PHARMACEUTICS (2012)
Can we cure cholangiocarcinoma with neoadjuvant chemoradiation and liver transplantation? Time for a multicenter trial
Robin K. Kelley et al.
LIVER TRANSPLANTATION (2012)
IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype
Sevin Turcan et al.
NATURE (2012)
Exome sequencing of liver fluke-associated cholangiocarcinoma
Choon Kiat Ong et al.
NATURE GENETICS (2012)
The role of cancer-associated myofibroblasts in intrahepatic cholangiocarcinoma
Alphonse E. Sirica
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
OPINION The biliary tree-a reservoir of multipotent stem cells
Vincenzo Cardinale et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2012)
Frequent Mutation of Isocitrate Dehydrogenase (IDH)1 and IDH2 in Cholangiocarcinoma Identified Through Broad-Based Tumor Genotyping
Darrell R. Borger et al.
ONCOLOGIST (2012)
Photodynamic therapy for unresectable cholangiocarcinoma: A comparative effectiveness systematic review and meta-analyses
Cadman L. Leggett et al.
PHOTODIAGNOSIS AND PHOTODYNAMIC THERAPY (2012)
Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil
Chariya Hahnvajanawong et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2012)
Multiple cells of origin in cholangiocarcinoma underlie biological, epidemiological and clinical heterogeneity
Vincenzo Cardinale et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2012)
Acquisition of chemoresistance in intrahepatic cholangiocarcinoma cells by activation of AKT and extracellular signal-regulated kinase (ERK)1/2
Hyunho Yoon et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2011)
Prognostic significance of overexpression of c-Met oncoprotein in cholangiocarcinoma
M. Miyamoto et al.
BRITISH JOURNAL OF CANCER (2011)
E/N-cadherin switch mediates cancer progression via TGF-β-induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma
K. Araki et al.
BRITISH JOURNAL OF CANCER (2011)
AJCC 7th Edition of TNM Staging Accurately Discriminates Outcomes of Patients With Resectable Intrahepatic Cholangiocarcinoma
Olivier Farges et al.
CANCER (2011)
The analysis of organic anion transporting polypeptide (OATP) mRNA and protein patterns in primary and metastatic liver cancer
Katrin Wlcek et al.
CANCER BIOLOGY & THERAPY (2011)
Different relation between ERCC1 overexpression and treatment outcomes of two platinum agents in advanced biliary tract adenocarcinoma patients
I. G. Hwang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Transarterial chemoembolization versus supportive therapy in the palliative treatment of unresectable intrahepatic cholangiocarcinoma
S. -Y. Park et al.
CLINICAL RADIOLOGY (2011)
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the Cholangiocarcinoma committee of the Italian Association for the Study of Liver disease
Domenico Alvaro et al.
DIGESTIVE AND LIVER DISEASE (2011)
Microsomal Prostaglandin E Synthase-1 Inhibits PTEN and Promotes Experimental Cholangiocarcinogenesis and Tumor Progression
Dongdong Lu et al.
GASTROENTEROLOGY (2011)
The H4 Histamine Receptor Agonist, Clobenpropit, Suppresses Human Cholangiocarcinoma Progression by Disruption of Epithelial Mesenchymal Transition and Tumor Metastasis
Fanyin Meng et al.
HEPATOLOGY (2011)
New Staging System and a Registry for Perihilar Cholangiocarcinoma
Michelle L. DeOliveira et al.
HEPATOLOGY (2011)
Nuclear Expression of S100A4 Calcium-Binding Protein Increases Cholangiocarcinoma Invasiveness and Metastasization
Luca Fabris et al.
HEPATOLOGY (2011)
Metabolic Syndrome Increases the Risk of Primary Liver Cancer in the United States: A Study in the SEER-Medicare Database
Tania M. Welzel et al.
HEPATOLOGY (2011)
Myofibroblast-Derived PDGF-BB Promotes Hedgehog Survival Signaling in Cholangiocarcinoma Cells
Christian D. Fingas et al.
HEPATOLOGY (2011)
Impact of bile acids on the growth of human cholangiocarcinoma via FXR
Jiaqi Dai et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2011)
Gene expression analysis for predicting gemcitabine resistance in human cholangiocarcinoma
Jun Sato et al.
JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2011)
Anandamide exerts its antiproliferative actions on cholangiocarcinoma by activation of the GPR55 receptor
Li Huang et al.
LABORATORY INVESTIGATION (2011)
Cholangiocarcinoma-controversies and challenges
Tushar Patel
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Clinical diagnosis and staging of cholangiocarcinoma
Boris Blechacz et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2011)
Pathological spectrum of intrahepatic cholangiocarcinoma arising in non-biliary chronic advanced liver diseases
Yasuni Nakanuma et al.
PATHOLOGY INTERNATIONAL (2011)
Liver transplantation for cholangiocarcinoma: Selection is essential for acceptable results
Styrbjorn Friman et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Strong expression of CD133 is associated with increased cholangiocarcinoma progression
Kawin Leelawat et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2011)
Trans-peritoneal fine needle aspiration biopsy of hilar cholangiocarcinoma is associated with disease dissemination
Julie K. Heimbach et al.
HPB (2011)
The clinical presentation and prognostic factors for intrahepatic and extrahepatic cholangiocarcinoma in a tertiary care centre
A. G. Singal et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2010)
Tumor-Associated Angiogenesis and Lymphangiogenesis Correlate With Progression of Intrahepatic Cholangiocarcinoma
Armin Thelen et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2010)
Epithelial-Mesenchymal Transition Induced by Transforming Growth Factor-β1/Snail Activation Aggravates Invasive Growth of Cholangiocarcinoma
Yasunori Sato et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Recent advances in the regulation of cholangiocarcinoma growth
Heather Francis et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2010)
The American Joint Committee on Cancer: the 7th Edition of the AJCC Cancer Staging Manual and the Future of TNM
Stephen B. Edge et al.
ANNALS OF SURGICAL ONCOLOGY (2010)
Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan
T. Okusaka et al.
BRITISH JOURNAL OF CANCER (2010)
Gemcitabine and oxaliplatin in patients with unresectable biliary cancer including gall bladder cancer: a Korean Cancer Study Group phase II trial
Joung-Soon Jang et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)
Silencing of Tousled-like kinase 1 sensitizes cholangiocarcinoma cells to cisplatin-induced apoptosis
Yuichi Takayama et al.
CANCER LETTERS (2010)
Significance of alternatively activated macrophages in patients with intrahepatic cholangiocarcinoma
Horlad Hasita et al.
CANCER SCIENCE (2010)
Circulating CD14+CD16+monocyte levels predict tissue invasive character of cholangiocarcinoma
C. Subimerb et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
An update on cholangiocarcinoma associated with primary sclerosing cholangitis
Johan Fevery et al.
CURRENT OPINION IN GASTROENTEROLOGY (2010)
Inflammation and oncogenesis: a vicious connection
Sergei I. Grivennikov et al.
CURRENT OPINION IN GENETICS & DEVELOPMENT (2010)
Opposing actions of endocannabinoids on cholangiocarcinoma growth is via the differential activation of Notch signaling
Gabriel Frampton et al.
EXPERIMENTAL CELL RESEARCH (2010)
Diagnosis and Management of Primary Sclerosing Cholangitis
Roger Chapman et al.
HEPATOLOGY (2010)
Estrogen Stimulates Female Biliary Epithelial Cell Interleukin-6 Expression in Mice and Humans
Kumiko Isse et al.
HEPATOLOGY (2010)
Secretin inhibits cholangiocarcinoma growth via dysregulation of the cAMP-dependent signaling mechanisms of secretin receptor
Paolo Onori et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
CD13 is a therapeutic target in human liver cancer stem cells
Naotsugu Haraguchi et al.
JOURNAL OF CLINICAL INVESTIGATION (2010)
Cisplatin plus Gemcitabine versus Gemcitabine for Biliary Tract Cancer.
Juan Valle et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Liver transplantation for cholangiocarcinoma
Charles B. Rosen et al.
TRANSPLANT INTERNATIONAL (2010)
Involvement of PI3K and ERK1/2 pathways in hepatocyte growth factor-induced cholangiocarcinoma cell invasion
Apaporn Menakongka et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2010)
Intra-hepatic and extra-hepatic cholangiocarcinoma: New insight into epidemiology and risk factors
Vincenzo Cardinale et al.
WORLD JOURNAL OF GASTROINTESTINAL ONCOLOGY (2010)
Prediction of breast cancer sensitivity to neoadjuvant chemotherapy based on status of DNA damage repair proteins
Hideki Asakawa et al.
BREAST CANCER RESEARCH (2010)
Hepatic Stellate Cells May Relate to Progression of Intrahepatic Cholangiocarcinoma
Hirohisa Okabe et al.
ANNALS OF SURGICAL ONCOLOGY (2009)
The antecedents of biliary cancer: a primary care case-control study in the United Kingdom
M. J. Grainge et al.
BRITISH JOURNAL OF CANCER (2009)
Molecular Mechanisms of Tamoxifen Therapy for Cholangiocarcinoma: Role of Calmodulin
Pritish Pawar et al.
CLINICAL CANCER RESEARCH (2009)
Serum and bile biomarkers for cholangiocarcinoma
Domenico Alvaro
CURRENT OPINION IN GASTROENTEROLOGY (2009)
Human cholangiocarcinoma development is associated with dysregulation of opioidergic modulation of cholangiocyte growth
M. Marzioni et al.
DIGESTIVE AND LIVER DISEASE (2009)
Estrogens stimulate the proliferation of human cholangiocarcinoma by inducing the expression and secretion of vascular endothelial growth factor
A. Mancino et al.
DIGESTIVE AND LIVER DISEASE (2009)
Cholangiocarcinoma in Cirrhosis: Absence of Contrast Washout in Delayed Phases by Magnetic Resonance Imaging Avoids Misdiagnosis of Hepatocellular Carcinoma
Jordi Rimola et al.
HEPATOLOGY (2009)
EASL Clinical Practice Guidelines: Management of cholestatic liver diseases
Ulrich Beuers et al.
JOURNAL OF HEPATOLOGY (2009)
N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas
Jean-Francois Mosnier et al.
MODERN PATHOLOGY (2009)
H3 Histamine Receptor-Mediated Activation of Protein Kinase Cα Inhibits the Growth of Cholangiocarcinoma In vitro and In vivo
Heather Francis et al.
MOLECULAR CANCER RESEARCH (2009)
Endothelin inhibits cholangiocarcinoma growth by a decrease in the vascular endothelial growth factor expression
Giammarco Fava et al.
LIVER INTERNATIONAL (2009)
Pharmacogenetics of the organic anion transporting polypeptide 1A2
Ryan M. Franke et al.
PHARMACOGENOMICS (2009)
EGFR and HER2 expression in advanced biliary tract cancer
Jan Harder et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2009)
Hepatitis B virus infection and intrahepatic cholangiocarcinoma in Korea: A case-control study
Tae Y. Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2008)
The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway
Sharon DeMorrow et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2008)
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study
T. Andre et al.
BRITISH JOURNAL OF CANCER (2008)
Treatment of Unresectable Cholangiocarcinoma Using Yttrium-90 Microspheres Results From a Pilot Study
Saad M. Ibrahim et al.
CANCER (2008)
Serotonin Metabolism Is Dysregulated in Cholangiocarcinoma, which Has Implications for Tumor Growth
Gianfranco Alpini et al.
CANCER RESEARCH (2008)
Leptin enhances cholangiocarcinoma cell growth
Giammarco Fava et al.
CANCER RESEARCH (2008)
Characterization of 5-fluorouracil-resistant cholangiocarcinoma cell lines
Nisana Namwat et al.
CHEMOTHERAPY (2008)
Enhanced expression of RAD51 associating protein-1 is involved in the growth of intrahepatic cholangiocarcinoma cells
Kazutaka Obama et al.
CLINICAL CANCER RESEARCH (2008)
Cholangiocarcinoma complicating primary sclerosing cholangitis: A 24-year experience
G. Morris-Stiff et al.
DIGESTIVE SURGERY (2008)
Expression of the multidrug resistance proteins MRP2 and MRP3 in human cholangiocellular carcinomas
S. Rau et al.
EUROPEAN JOURNAL OF CLINICAL INVESTIGATION (2008)
Clinicopathological study on cholangiolocellular carcinoma suggesting hepatic progenitor cell origin
Mina Komuta et al.
HEPATOLOGY (2008)
Microvessel density correlates with lymph node metastases and prognosis in hilar cholangiocarcinoma
Armin Thelen et al.
JOURNAL OF GASTROENTEROLOGY (2008)
Expression of multidrug resistance-associated protein 1 in hepatocellular carcinoma is associated with a more aggressive tumour phenotype and may reflect a progenitor cell origin
Sara Vander Borght et al.
LIVER INTERNATIONAL (2008)
Clinicopathological and prognostic significance of EGFR, VEGF, and HER2 expression in cholangiocarcinoma
D. Yoshikawa et al.
BRITISH JOURNAL OF CANCER (2008)
Peripheral mass - Forming Cholangiocarcinoma in cirrhotic liver
Su Jin Kim et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2007)
Trends in survival after surgery for cholangiocarcinoma: A 30-year population-based SEER database analysis
Hari Nathan et al.
JOURNAL OF GASTROINTESTINAL SURGERY (2007)
Serum and biliary insulin-like growth factor I and vascular endothelial growth factor in determining the cause of obstructive cholestasis
Domenico Alvaro et al.
ANNALS OF INTERNAL MEDICINE (2007)
Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis
Einar Bjornsson et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2007)
Opposing actions of endocannabinoids on cholangiocarcinoma growth - Recruitment of Fas and Fas ligand to lipid rafts
Sharon DeMorrow et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Disrupting insulin-like growth factor signaling as a potential cancer therapy
Deepali Sachdev et al.
MOLECULAR CANCER THERAPEUTICS (2007)
Sustained IL-6/STAT-3 signaling in cholangiocarcinoma cells due to SOCS-3 epigenetic silencing
Hajime Isomoto et al.
GASTROENTEROLOGY (2007)
Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression
Hania Wehbe et al.
CANCER RESEARCH (2006)
Estrogens and insulin-like growth factor 1 modulate neoplastic cell growth in human cholangiocarcinoma
Domenico Alvaro et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Over-expression of interleukin-6 enhances cell survival and transformed cell growth in human malignant cholangiocytes
Fanyin Meng et al.
JOURNAL OF HEPATOLOGY (2006)
Endogenous opioids modulate the growth of the biliary tree in the course of cholestasis
Marco Marzioni et al.
GASTROENTEROLOGY (2006)
Possible regulation of migration of intrahepatic cholangiocarcinoma cells by interaction of CXCR4 expressed in carcinoma cells with tumor necrosis factor-α and stromal-derived factor-1 released in stroma
S Ohira et al.
AMERICAN JOURNAL OF PATHOLOGY (2006)
Expression of IGF-I, IGF-II, and IGF-IR in gallbladder carcinoma.: A systematic analysis including primary and corresponding metastatic tumours
P Kornprat et al.
JOURNAL OF CLINICAL PATHOLOGY (2006)
γ-Aminobutyric acid inhibits cholangiocarcinoma growth by cyclic AMP-dependent regulation of the protein kinase A/extracellular signal-regulated kinase 1/2 pathway
G Fava et al.
CANCER RESEARCH (2005)
Interleukin 6 upregulates myeloid cell leukemia-1 expression through a STAT3 pathway in cholanglocarcinoma cells
H Isomoto et al.
HEPATOLOGY (2005)
Detection of response-predicting mutations in the kinase domain of the epidermal growth factor receptor gene in cholangiocarcinomas
GY Gwak et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2005)
The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis
C Levy et al.
DIGESTIVE DISEASES AND SCIENCES (2005)
Amplification and overexpression of c-erbB-2, epidermal growth factor receptor, and c-met in biliary tract cancers
K Nakazawa et al.
JOURNAL OF PATHOLOGY (2005)
Interleukin-6 contributes to Mcl-1 up-regulation and TRAIL resistance via an Akt-signaling pathway in cholangiocarcinoma cells
S Kobayashi et al.
GASTROENTEROLOGY (2005)
Drug sensitivity and drug resistance profiles of human intrahepatic cholangiocarcinoma cell lines
Nisana Tepsiri et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2005)
Promoter hypermethylation is a major event of hMLH1 gene inactivation in liver fluke related cholangiocarcinoma
T Limpaiboon et al.
CANCER LETTERS (2005)
Celecoxib-induced apoptosis in rat cholangiocarcinoma cells mediated by Akt inactivation and Bax translocation
ZC Zhang et al.
HEPATOLOGY (2004)
Prognostic factors in node-negative intrahepatic cholangiocarcinoma with special reference to angiogenesis
K Shirabe et al.
AMERICAN JOURNAL OF SURGERY (2004)
Oxysterols induce cyclooxygenase-2 expression in cholangiocytes: Implications for biliary tract carcinogenesis
JH Yoon et al.
HEPATOLOGY (2004)
Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis
K Burak et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Cyclooxygenase-2 promotes human cholangiocarcinoma growth:: Evidence for cyclooxygenase-2-independent mechanism in celecoxib-mediated induction of p21Waf1/cip1 and p27kip1 and cell cycle arrest
C Han et al.
CANCER RESEARCH (2004)
ERCP or EUS for tissue diagnosis of biliary strictures?: A prospective comparative study
T Rösch et al.
GASTROINTESTINAL ENDOSCOPY (2004)
Yield of endoscopic ultrasound-guided fine-needle aspiration of bile duct lesions
MF Byrne et al.
ENDOSCOPY (2004)
The therapeutic potential of agents targeting the type I insulin-like growth factor receptor
H Zhang et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2004)
Inducible nitric oxide synthase upregulates cyclooxygenase-2 in mouse cholangiocytes promoting cell growth
N Ishimura et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2004)
Enhanced epidermal growth factor receptor activation in human cholangiocarcinoma cells
JH Yoon et al.
JOURNAL OF HEPATOLOGY (2004)
EUS-guided fine-needle aspiration of suspected hilar cholangiocarcinorna in potentially operable patients with negative brush cytology
A Fritscher-Ravens et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Endoscopic ultrasound and fine-needle aspiration of unexplained bile duct strictures
JH Lee et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2004)
Mcl-1 mediates tumor necrosis factor-related apoptosis-inducing ligand resistance in human cholangiocarcinoma cells
M Taniai et al.
CANCER RESEARCH (2004)
Magnetic resonance cholangiopancreatography: A meta-analysis of test performance in suspected biliary disease
J Romagnuolo et al.
ANNALS OF INTERNAL MEDICINE (2003)
Reversal of multiple drug resistance in cholangiocarcinoma by the glutathione S-transferase-π-specific inhibitor O1-hexadecyl-γ-glutamyl-S-benzylcysteinyl-D-phenylglycine ethylester
T Nakajima et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2003)
Bile acids activate EGF receptor via a TGF-α-dependent mechanism in human cholangiocyte cell lines
NW Werneburg et al.
AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY (2003)
In situ detection of TGF betas, TGF beta receptor II mRNA and telomerase activity in rat cholangiocarcinogenesis
JP Lu et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2003)
Successful photodynamic therapy for nonresectable cholangiocarcinoma: A randomized prospective study
MEJ Ortner et al.
GASTROENTEROLOGY (2003)
Microsatellite instability in thorotrast-induced human intrahepatic cholangiocarcinoma
D Liu et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Comparative immunohistochemical profile of hepatocellular carcinoma, cholangiocarcinoma, and metastatic adenocarcinoma
SK Lau et al.
HUMAN PATHOLOGY (2002)
Cholangiocarcinoma in primary sclerosing cholangitis:: Risk factors and clinical presentation
KM Boberg et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2002)
Cyclooxygenase-2 and ERBB-2 in cholangiocarcinoma: Potential therapeutic targets
AE Sirica et al.
SEMINARS IN LIVER DISEASE (2002)
A prospective comparison of the diagnostic accuracy of ERCP, MRCP, CT, and EUS in biliary strictures
T Rösch et al.
GASTROINTESTINAL ENDOSCOPY (2002)
Bile acids induce cyclooxygenase-2 expression via the epidermal growth factor receptor in a human cholangiocarcinoma cell line
JH Yoon et al.
GASTROENTEROLOGY (2002)
Cost comparison of endoscopic stenting vs surgical treatment for unresectable cholangiocarcinoma.
RCG Martin et al.
SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES (2002)
Using CT and cholangiography to diagnose biliary tract carcinoma complicating primary sclerosing cholangitis
WL Campbell et al.
AMERICAN JOURNAL OF ROENTGENOLOGY (2001)
Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma
WR Jarnagin et al.
ANNALS OF SURGERY (2001)
High expression of thymidylate synthase leads to resistance to 5-fluorouracil in biliary tract carcinoma in vitro
K Habara et al.
JAPANESE JOURNAL OF CANCER RESEARCH (2001)
Microsatellite instability and alternative genetic pathway in intrahepatic cholangiocarcinoma
H Momoi et al.
JOURNAL OF HEPATOLOGY (2001)
Gastrin inhibits cholangiocarcinoma growth through increased apoptosis by activation of Ca2+-dependent protein kinase C-α
N Kanno et al.
JOURNAL OF HEPATOLOGY (2001)
Nitric oxide-mediated inhibition of DNA repair potentiates oxidative DNA damage in cholangiocytes
M Jaiswal et al.
GASTROENTEROLOGY (2001)
Molecular identification and functional characterization of Mdr1a in rat cholangiocytes
A Gigliozzi et al.
GASTROENTEROLOGY (2000)
EUS-guided fine-needle aspiration cytodiagnosis of hilar cholangiocarcinoma: a case
A Fritscher-Ravens et al.
GASTROINTESTINAL ENDOSCOPY (2000)
Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis
A Rullier et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2000)
Expression and antitumor effects of TRAIL in human cholangiocarcinoma
S Tanaka et al.
HEPATOLOGY (2000)
Share Paper
